Chase Games

. @JayWoods3 has some spider sense; there's something to be said about the Friday trades on $SPX

@jd_durkin biggest holding in $IGV 👀

🚨 wow... $MSFT just delivered its best trading day of 2026, rallying over 3.6% in a single session.

$XOM at YTD volume shelf, momentum trying to turn overhead supply at 161

@inprobabilities interesting measure to use. essentially high-beta speculative/decentralized vs high-beta institutional/enterprise.

Been watching the BTC/IGV ratio for exactly this reason. If IGV loses the pivot, the ratio breakout above the 200-day confirms. If IGV holds, ratio likely fails back. Same story, two angles. #BTC $IGV

@hstaater would refer you to this one. still stands today

@chasecharting check nvda/mags too, right at a big spot

$NVDA this looks familiar coiling under the 1.618 with MACD rolling over, similar to the setup ahead of the early 2024 breakout

Make or break support levels for $IGV coming from cycle-based Fibonacci and COVID-anchored VWAP

$IGV still selling off but its long-term trend remains intact unless this rising support channel from the 2008 lows breaks. Stoch oversold has aligned with prior retests.

$NVDA currently at an all-time-high versus the Mag7 (ex-Nvidia) basket of $AAPL $AMZN $MSFT $GOOGL $META $TSLA

$NVDA through resistance, next levels 194 and 205

Notice how several major $SPX $SPY inflection points have aligned with April monthly candles across cycles Worth watching as Q2 begins

Almost exactly one year later… $SPX $SPY with another headline-driven squeeze Different catalyst, same reaction

$XOM set to close below the 20-day MA for the first time in 2026

$NVDA breaking above $180 would confirm this inverse H&S and could push $SPY $SPX higher

Happy Easter 🐣

$TAN stalling at resistance after a multi-year base Above $55 opens a quick move through the volume gap toward ~$67, where anchored supply awaits

Microsoft nearing a multi-year floor that aligns with the 'golden ratio' and is deeply oversold $MSFT $SPY $IGV

$PFE $XLV $SPY "boring but beautiful" Pfizer is pressing up against ~$28 ceiling with relative strength vs XLV turning higher + stochastic 'bull' crossover

$T holding pattern resembles a bull flag. The measured breakout establishes a target of $31. MACD needs crossover for true confirmation.